Influence of Adriamycin Dose in the Outcome of Patients with Osteosarcoma Treated with Multidrug Neoadjuvant Chemotherapy: Results of Two Sequential Studies
Author:
Publisher
Informa UK Limited
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology
Link
http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883
Reference15 articles.
1. Campanacci M, Bacci G, Bertoni F et al. The treatment of osteosarcoma of the extremities: twenty years’ experience at the Istituto Ortopedico Rizzoli. Cancer, 1981; 48: 1569–1581.
2. Rosen G. Preoperative chemotherapy (neoadjuvant) chemotherapy for osteogenic sarcoma: a ten years experience. Orthopaedics, 1985; 8: 659–664.
3. Winkler K, Bieling P, Bielack S et al. Local control and survival from the Cooperative Osteosarcoma Group Studies of the German Society of Pediatric Oncology and the Vienna Bone Tumor Registry. Clin Orthopaed, 1991; 270: 79–86.
4. Link MP, Goorin AM, Miser AW et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremities. N Engl J Med, 1986; 314: 1600–1606.
5. Bacci G, Picci P, Ruggieri P et al. Primary chemotherapy and delayed surgery (Neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Rizzoli experience in 127 patients treated preoperatively with Methotrexate i.v. (high vs moderate dose) and Cisplatinum i.a. Cancer, 1990; 65, 2539–2553.
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better?;South Asian Journal of Cancer;2023-04-10
2. Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies;International Journal of Molecular Sciences;2020-09-19
3. Sarcomas of Bone;Abeloff's Clinical Oncology;2020
4. Combination Therapy with Disulfiram, Copper, and Doxorubicin for Osteosarcoma: In Vitro Support for a Novel Drug Repurposing Strategy;Sarcoma;2019-07-11
5. Fertility, Cardiac, and Orthopedic Challenges in Survivors of Adult and Childhood Sarcoma;American Society of Clinical Oncology Educational Book;2017-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3